Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: The number of patients with non-HIV Pneumocystis pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We investigated the clinical characteristics of non-HIV PCP and its association with microbiological genotypes. Methods: Between January 2005 and March 2010, all patients in 2 university hospitals who had been diagnosed with PCP by PCR were enrolled in this study. Retrospective chart review of patients, microbiological genotypes, and association with 30-day mortality were examined. Results: Of the 82 adult patients investigated, 50 patients (61%) had inflammatory diseases, 17 (21%) had solid malignancies, 12 (15%) had hematological malignancies, and 6 (7%) had received transplantations. All patients received immunosuppressive agents or antitumor chemotherapeutic drugs. Plasma (1→3) β-D-glucan levels were elevated in 80% of patients, and were significantly reduced after treatment in both survivors and non-survivors. However, β-D-glucan increased in 18% of survivors and was normal in only 33% after treatment. Concomitant invasive pulmonary aspergillosis was detected in 5 patients. Fifty-six respiratory samples were stored for genotyping. A dihydropteroate synthase mutation associated with trimethoprim-sulfamethoxazole resistance was found in only 1 of the 53 patients. The most prevalent genotype of mitochondrial large-subunit rRNA was genotype 1, followed by genotype 4. The most prevalent genotype of internal transcribed spacers of the nuclear rRNA operon was Eb, followed by Eg and Bi. Thirty-day mortality was 24%, in which logistic regression analysis revealed association with serum albumin and mechanical ventilation, but no association with genotypes. Conclusions: In non-HIV PCP, poorer general and respiratory conditions at diagnosis were independent predictors of mortality. β-D-glucan may not be useful for monitoring the response to treatment, and genotypes were not associated with mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Helweg-Larsen, J., Benfield, T. L., Eugen-Olsen, J., Lundgren, J. D., & Lundgren, B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03320-6 · Cited by 274 · cited 1×
“The DHPS mutation is thought to be associated with failure of treatment and prophylaxis [15,16].”
BackgroundBeard, C. B., Carter, J. L., Keely, S. P., Huang, L., Pieniazek, N. J., Moura, I. N. S., Roberts, J. M., Hightower, A. W., Bens, M. S., Freeman, A. R., et al. (2000) · Emerging infectious diseases · doi:10.3201/eid0603.000306 · Cited by 241 · cited 1×
“Other studies for HIV PCP, non-HIV PCP, and non-HIV patients without pneumonia found that genotypes 1 or 2 were the most prevalent, and genotype 4 was the least prevalent [20,40,42-45].”
BackgroundKazanjian, P., Armstrong, W., Hossler, P. A., Burman, W., Richardson, J., Lee, C., Crane, L., Katz, J., & Meshnick, S. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315719 · Cited by 164 · cited 1×
“In addition, the prophylactic use of TMPSMX may be associated with the emergence of DHPS mutant strains in HIV patients [39].”
BackgroundPneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment
Krajicek, B. J., Thomas, C. F., & Limper, A. H. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.005 · Cited by 73 · cited 1×
“more sensitive polymerase chain reaction (PCR) test has recently been employed [6,7].”
MethodTakahashi, T., Hosoya, N., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., & Iwamoto, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3161-3164.2000 · Cited by 69
Cited by
Alanio, A., Hauser, P. M., Lagrou, K., Melchers, W. J. G., Helweg-Larsen, J., Matos, O., Cesaro, S., Maschmeyer, G., Einsele, H., Donnelly, J. P., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw156 · Cited by 417
Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis
Isenor, J. E., Edwards, N. T., Alia, T. A., Slayter, K. L., MacDougall, D. M., McNeil, S. A., & Bowles, S. K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.08.085 · Cited by 267
Cooley, L., Dendle, C., Wolf, J., Teh, B. W., Chen, S. C., Boutlis, C., & Thursky, K. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12599 · Cited by 228
Tasaka, S., & Tokuda, H. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0453-0 · Cited by 123
Pneumocystis jirovecii pneumonia in kidney transplantation
Goto, N., & Oka, S. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00691.x · Cited by 74
Metadata
- Authors
- Matsumura, Y., Shindo, Y., Iinuma, Y., Yamamoto, M., Shirano, M., Matsushima, A., Nagao, M., Ito, Y., Takakura, S., Hasegawa, Y., & Ichiyama, S.
- Venue
- BMC Infectious Diseases
- Published
- 2011-03-25
- Volume
- 11
- Issue
- 1
- Pages
- 76-76
- ISSN
- 1471-2334 (ISSN-L)
- OpenAlex
- W2046538781
- Cited by
- 112
- References
- 6
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. https://app.cochat.ai/papers/10.1186/1471-2334-11-76
- The paper
- Matsumura, Y., Shindo, Y., Iinuma, Y., Yamamoto, M., Shirano, M., Matsushima, A., Nagao, M., Ito, Y., Takakura, S., Hasegawa, Y., & Ichiyama, S. (2011). Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-11-76
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.